ProMIS Neurosciences, Inc. (PMN)
12.30
+0.25
(+2.07%)
USD |
NASDAQ |
Apr 15, 16:00
12.20
-0.10
(-0.81%)
Pre-Market: 20:00
ProMIS Neurosciences Shareholders Equity (Quarterly) : -1.259M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Oncolytics Biotech, Inc. | -3.799M |
| Aurinia Pharmaceuticals, Inc. | 581.33M |
| Edesa Biotech, Inc. | 13.95M |
| Lexaria Bioscience Corp. | 6.602M |
| Xenon Pharmaceuticals, Inc. | 581.76M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 9.182M |
| Total Liabilities (Quarterly) | 10.44M |
| Current Ratio | 0.8788 |